{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:11:21Z","timestamp":1787771481866,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cll.2024.04.014","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T12:02:58Z","timestamp":1717070578000},"page":"551-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessing Direct Oral Anticoagulants in the Clinical Laboratory"],"prefix":"10.1016","volume":"44","author":[{"given":"Robert C.","family":"Gosselin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Cuker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cll.2024.04.014_bib1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.cll.2024.04.014_bib2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3949\/ccjm.82a.14052","article-title":"The new oral anticoagulants: reasonable alternatives to warfarin","volume":"82","author":"Roca","year":"2015","journal-title":"Cleve Clin J Med"},{"issue":"19","key":"10.1016\/j.cll.2024.04.014_bib3","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.cll.2024.04.014_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11239-015-1282-7","article-title":"Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication","volume":"41","author":"Cuker","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"6","key":"10.1016\/j.cll.2024.04.014_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.25475","article-title":"Reversal of direct oral anticoagulants: guidance from the anticoagulation forum","volume":"94","author":"Cuker","year":"2019","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.cll.2024.04.014_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archinte.1994.00420030084008","article-title":"The international normalized ratio. A guide to understanding and correcting its problems","volume":"154","author":"Hirsh","year":"1994","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.cll.2024.04.014_bib8","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/jth.13266","article-title":"The laboratory's 2015 perspective on direct oral anticoagulant testing","volume":"14","author":"Gosselin","year":"2016","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"7","key":"10.1016\/j.cll.2024.04.014_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/1060028015578451","article-title":"Heparin-calibrated chromogenic anti-Xa activity measurements in patients receiving rivaroxaban: can this test be used to quantify drug level?","volume":"49","author":"Gosselin","year":"2015","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.cll.2024.04.014_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/1060028018811657","article-title":"Anti-Xa oral anticoagulant plasma concentration assay in real life: rivaroxaban and apixaban quantification in emergency with LMWH calibrator","volume":"53","author":"Billoir","year":"2019","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.cll.2024.04.014_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/ijlh.12528","article-title":"Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays","volume":"38","author":"Gosselin","year":"2016","journal-title":"Int J Lab Hematol"},{"issue":"11","key":"10.1016\/j.cll.2024.04.014_bib13","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1111\/jth.15884","article-title":"The myths behind DOAC measurement: analyses of prescribing information from different regulatory bodies and a call for harmonization","volume":"20","author":"Gosselin","year":"2022","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2024.04.014_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/ijlh.12658","article-title":"The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue","volume":"39","author":"Adcock","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"10.1016\/j.cll.2024.04.014_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0038-1627480","article-title":"International council for standardization in haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants","volume":"118","author":"Gosselin","year":"2018","journal-title":"Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.cll.2024.04.014_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH14-04-0361","article-title":"Evaluating the use of commercial drug-specific calibrators for determining PT and APTT reagent sensitivity to dabigatran and rivaroxaban","volume":"113","author":"Gosselin","year":"2015","journal-title":"Thromb Haemostasis"},{"issue":"7","key":"10.1016\/j.cll.2024.04.014_bib18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.pathol.2016.07.008","article-title":"Sensitivity of routine coagulation assays to direct oral anticoagulants: patient samples versus commercial drug-specific calibrators","volume":"48","author":"Lim","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.cll.2024.04.014_bib19","article-title":"International Council for Standardization in Haematology field study evaluating optimal interpretation methods for activated partial thromboplastin time and prothrombin time mixing studies","author":"Gosselin","year":"2023","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"10.1016\/j.cll.2024.04.014_bib20","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1055\/a-1450-8178","article-title":"2021\u00a0Update of the international council for standardization in haematology recommendations for laboratory measurement of direct oral anticoagulants","volume":"121","author":"Douxfils","year":"2021","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.cll.2024.04.014_bib21","doi-asserted-by":"crossref","first-page":"991675","DOI":"10.3389\/fcvm.2022.991675","article-title":"The impact of direct oral anticoagulants on viscoelastic testing - a systematic review","volume":"9","author":"Sahli","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"01","key":"10.1016\/j.cll.2024.04.014_bib22","first-page":"191","article-title":"Accurate determination of rivaroxaban levels requires different calibrator sets but not addition of antithrombin","volume":"108","author":"Mani","year":"2012","journal-title":"Thromb Haemostasis"},{"issue":"12","key":"10.1016\/j.cll.2024.04.014_bib23","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.5858\/arpa.2013-0750-OA","article-title":"Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxaban","volume":"138","author":"Gosselin","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.cll.2024.04.014_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0036-1597296","article-title":"Laboratory assessment of direct oral anticoagulants","volume":"43","author":"Douxfils","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cll.2024.04.014_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40495-020-00232-7","article-title":"Overview and practical application of coagulation assays in managing anticoagulation with direct oral anticoagulants (DOACs)","volume":"6","author":"Rimsans","year":"2020","journal-title":"Curr Pharmacol Rep"},{"issue":"1","key":"10.1016\/j.cll.2024.04.014_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","article-title":"Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: a systematic review","volume":"151","author":"Samuelson","year":"2017","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.cll.2024.04.014_bib27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1309\/AJCPRNUMI4PVSJ7Q","article-title":"Performance of various laboratory assays in the measurement of dabigatran in patients receiving therapeutic doses: a prospective study based on peak and trough plasma levels","volume":"141","author":"Gosselin","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2024.04.014_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12959-016-0084-2","article-title":"Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting","volume":"14","author":"Brunetti","year":"2016","journal-title":"Thromb J"},{"issue":"7","key":"10.1016\/j.cll.2024.04.014_bib29","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ajh.25852","article-title":"Ecarin based coagulation testing","volume":"95","author":"Gosselin","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cll.2024.04.014_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4939-7196-1_18","article-title":"Measuring direct oral anticoagulants","volume":"1646","author":"Gosselin","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2024.04.014_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ijlh.12992","article-title":"An update on laboratory assessment for direct oral anticoagulants (DOACs)","volume":"41","author":"Gosselin","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"10.1016\/j.cll.2024.04.014_bib33","doi-asserted-by":"crossref","first-page":"e001018","DOI":"10.1136\/lupus-2023-001018","article-title":"Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials","volume":"10","author":"Adelhelm","year":"2023","journal-title":"Lupus Sci Med"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2024.04.014_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/ijlh.13585","article-title":"Review of coagulation preanalytical variables with update on the effect of direct oral anticoagulants","volume":"43","author":"Gosselin","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"9","key":"10.1016\/j.cll.2024.04.014_bib35","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1055\/a-1753-2748","article-title":"DOAC dipstick testing can reliably exclude the presence of clinically relevant DOAC concentrations in circulation","volume":"122","author":"Margeti\u0107","year":"2022","journal-title":"Thromb Haemostasis"},{"issue":"10","key":"10.1016\/j.cll.2024.04.014_bib36","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1055\/s-0042-1750327","article-title":"Performance of a qualitative point-of-care strip test to detect DOAC exposure at the emergency department: a cohort-type cross-sectional diagnostic accuracy study","volume":"122","author":"Merrelaar","year":"2022","journal-title":"Thromb Haemostasis"},{"key":"10.1016\/j.cll.2024.04.014_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231179684","article-title":"Comparison of the DOAC Dipstick test on urine samples with chromogenic substrate methods on plasma samples in outpatients treated with direct oral anticoagulants","volume":"29","author":"Papageorgiou","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"issue":"Supplement 2","key":"10.1016\/j.cll.2024.04.014_bib38","first-page":"75","article-title":"QC.15: a novel point-of-care whole blood portable analyzer for direct oral anticoagulant monitoring","volume":"7","author":"Cuker","year":"2023","journal-title":"Res Pract Thromb Haemosta"},{"issue":"3","key":"10.1016\/j.cll.2024.04.014_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-0038-1676317","article-title":"A\u00a0novel whole blood point-of-care coagulometer to measure the effect of direct oral anticoagulants and heparins","volume":"45","author":"Ansell","year":"2019","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.cll.2024.04.014_bib40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11239-017-1477-1","article-title":"Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system","volume":"43","author":"Bliden","year":"2017","journal-title":"J\u00a0Thromb Thrombolysis"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271224000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271224000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T12:33:00Z","timestamp":1722429180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271224000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0272271224000258"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2024.04.014","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing Direct Oral Anticoagulants in the Clinical Laboratory","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2024.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}